Viewing nowCombinationSitagliptin/Metformin Extended-Release Tablets 100/1000 mg
Sitagliptin Hydrochloride Hydrate 113.37mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
TDS Pharm Co., Ltd.

MFDS item code 202300614 · Approved 2023.02.17 · Insurance code 679802190
Improvement of glycemic control in type 2 diabetes
This medicine is used to help patients with type 2 diabetes control their blood sugar levels. Sitagliptin and metformin work together to effectively improve blood glucose levels. These medications assist in diabetes management in conjunction with diet and exercise. Therefore, this medicine plays an important role in the treatment of type 2 diabetes and contributes to improving patients' health status. This medicine is used to improve blood glucose control.
In antidiabetic therapy, the dosage of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: sitagliptin 100 mg and metformin 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, this drug should be taken with a meal once daily, preferably in the evening, and the dosage should be increased gradually. Take 1 tablet of this drug 100/1000 mg extended-release tablets once daily. Patients taking this drug 50/500 mg extended-release tablets or 50/1000 mg extended-release tablets should take 2 tablets together once daily. 1. Patients not currently receiving metformin: For patients with no prior experience with antidiabetic drug therapy whose blood glucose is not adequately controlled with monotherapy, or for whom adequate blood glucose control cannot be achieved with sitagliptin monotherapy, the initial total daily dose of this drug is sitagliptin 100 mg and metformin 1000 mg. If adequate blood glucose control cannot be achieved with the initial dose, the dose may be increased gradually up to the maximum recommended daily dose of metformin, 2000 mg, to reduce gastrointestinal adverse reactions caused by metformin. 2. Patients receiving metformin: - For patients whose blood glucose is not adequately controlled with metformin monotherapy, the recommended initial total daily dose of this drug is sitagliptin 100 mg and the patient's current metformin dose. - Patients switching from combination therapy with sitagliptin and metformin to this drug may start at their current doses of sitagliptin and metformin. - Patients receiving metformin immediate-release tablets at a dose of 850 mg or 1000 mg twice daily may start with 2 tablets of this drug 50/1000 mg extended-release tablets once daily. 3. Patients whose blood glucose is not adequately controlled with combination therapy of metformin and a sulfonylurea, metformin and insulin, or metformin and a thiazolidinedione: The initial total daily dose of this drug is sitagliptin 100 mg, and the initial dose of metformin should be determined based on the patient's blood glucose level and current dose. The dosage should be increased gradually to reduce gastrointestinal adverse reactions caused by metformin. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Patients with renal impairment This drug may be used in patients with moderate renal impairment stage 3a (creatinine clearance [CrCl] ≥ 45 and < 60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 and < 60 mL/min/1.73m2) who have no other condition that may increase the risk of lactic acidosis, with the following dosage adjustment. Treatment should not be initiated with this drug because the starting dose of metformin is 500 mg or 850 mg once daily. The maximum recommended dose of metformin is 1000 mg daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 mL/min or eGFR < 45 mL/min/1.73m2, this drug should be discontinued immediately.
This medicine contains both sitagliptin and metformin and is used for diabetes treatment. Firstly, caution should be taken as serious allergic reactions may occur during the use of this medicine. If symptoms such as rash, hives, difficulty in breathing, or swelling of the face or neck occur, discontinue use immediately and consult a doctor. Additionally, acute pancreatitis, which is inflammation of the pancreas, may rarely occur, so if symptoms like abdominal pain, nausea, vomiting, or fever occur, a hospital visit should be made immediately. The metformin component in this medicine can cause a serious metabolic complication called lactic acidosis, which can be very rare but fatal, so caution is advised. Symptoms of lactic acidosis include shortness of breath, muscle pain, weakness, abdominal pain, and abnormal breathing; if these symptoms occur, inform medical personnel immediately. Patients with reduced kidney function or severe liver disease should not take this medicine, and kidney function should be regularly monitored even when kidney function is only slightly decreased. This medicine should be discontinued in specific situations, for example, during dehydration, severe infections, heart disease, and before and after surgeries, as well as before and after undergoing tests with radiopaque contrast agents, and the decision to continue should be made in consultation with a physician. There is also a risk of hypoglycemia; therefore, especially when taking insulin or other antihyperglycemic agents, blood glucose levels should be checked frequently and symptoms of hypoglycemia should be monitored diligently. Excessive alcohol consumption can increase the risk of side effects from this medicine, so it should be avoided during treatment. It is safer for women who are pregnant or may become pregnant, as well as those who are breastfeeding, to avoid this medicine. In children, the safety and effectiveness have not been sufficiently established, and it is not recommended for those under 18 years of age. Finally, it is important to continuously manage health status by maintaining regular meals, exercise, and regular monitoring of blood glucose and kidney function while taking this medicine.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly closed container, protected from exposure to air and moisture, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way will help safely maintain the effectiveness of the medicine.
Light blue, oval-shaped, bi-convex extended-release film-coated tablets
Bottle - 100 tablets/bottle, Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 113.37mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
TDS Pharm Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.